Clinical Trial Update: Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

View source ↗

Summary

This clinical trial update discusses using plasma circulating DNA as a biomarker to monitor treatment response in head and neck cancer and esophageal cancer; no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Head and Neck Cancer

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Head and Neck Cancer, Esophageal Cancer | Status: UNKNOWN